The use of warfarin in veterans with atrial fibrillation

The use of warfarin in veterans with atrial fibrillation

Bibliographic Details
Main Authors:	Bravata, Dawn M, Rosenbeck, Karen, Kancir, Sue, Brass, Lawrence M
Format:	Online
Language:	English
Published:	BioMed Central 2004
Online Access:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC526776/

Similar Items

The Anticoagulation in Patients with Atrial Fibrillation: Rivaroxaban and Warfarin
by: I. Yu. Koroleva, et al.
Published: (2016-01-01)

Warfarin and atrial fibrillation: from ideal to real the warfarin affaire
by: Molteni, Mauro, et al.
Published: (2014)

Warfarin use in hemodialysis patients with atrial fibrillation: decisions based on uncertainty
by: Juma, Salima, et al.
Published: (2013)

Improving outpatient warfarin use for hospitalized patients with atrial fibrillation
by: Touchette, Daniel R., et al.
Published: (2008)

Patterns of warfarin use and subsequent outcomes in atrial fibrillation in primary care practices
by: Ewen, Edward, et al.
Published: (2012)

Survey of the use of warfarin and the newer anticoagulant dabigatran in patients with atrial fibrillation
by: Choi, Jiyoon C, et al.
Published: (2014)

ANALYSIS OF DIRECT COSTS ASSOCIATED WITH THE USE OF WARFARIN IN PATIENTS WITH ATRIAL FIBRILLATION
by: Yu. B. Belousov, et al.
Published: (2011-01-01)

Warfarin doses for anticoagulation therapy in elderly patients with chronic atrial fibrillation
by: de Padua Mansur, Antonio, et al.
Published: (2012)

Effectiveness and Safety of Dabigatran, Rivaroxaban, and Apixaban Versus Warfarin in Nonvalvular Atrial Fibrillation
by: Yao, Xiaoxi, et al.
Published: (2016)

Native valve disease in patients with non-valvular atrial fibrillation on warfarin or rivaroxaban
by: Breithardt, Günter, et al.
Published: (2016)

The cost of monitoring warfarin in patients with chronic atrial fibrillation in primary care in Sweden
by: Björholt, Ingela, et al.
Published: (2007)

Initiation and Persistence with Warfarin Therapy in Atrial Fibrillation According to Ethnicity
by: Hansen, Carolina Malta, et al.
Published: (2012)

Cost-Effectiveness of Apixaban Compared with Warfarin for Stroke Prevention in Atrial Fibrillation
by: Lee, Soyon, et al.
Published: (2012)

Association of GGCX gene polymorphism with warfarin dose in atrial fibrillation population in Xinjiang
by: Kamali, Xiayizha, et al.
Published: (2013)

Economic Evaluation of Warfarin, Dabigatran, Rivaroxaban, and Apixaban for Stroke Prevention in Atrial Fibrillation
by: Wisløff, Torbjørn, et al.
Published: (2014)

The Association Between Bleeding and the Incidence of Warfarin Discontinuation in Patients with Atrial Fibrillation
by: Simon, Teresa A., et al.
Published: (2016)

Dabigatran Versus Warfarin for Direct Current Cardioversion in Atrial Fibrillation
by: Benamer, Sufyan, et al.
Published: (2016)

International Normalized Ratio Stability in Warfarin-Experienced Patients with Nonvalvular Atrial Fibrillation
by: Nelson, Winnie W., et al.
Published: (2015)

Left atrial appendage closure in patients with atrial fibrillation in whom warfarin is contra-indicated: initial South African experience
by: Abelson, Mark
Published: (2013)

Rivaroxaban as an effective alternative to warfarin in a patient with atrial fibrillation, thrombophilia, and left atrial appendage thrombus: a case report
by: Michele Scarano, et al.
Published: (2017-04-01)

Cost effectiveness of left atrial appendage closure with the Watchman device for atrial fibrillation patients with absolute contraindications to warfarin
by: Reddy, Vivek Y., et al.
Published: (2016)

Stability of High‐Quality Warfarin Anticoagulation in a Community‐Based Atrial Fibrillation Cohort: The Anticoagulation and Risk Factors in Atrial Fibrillation (ATRIA) Study
by: Dallalzadeh, Liane O., et al.
Published: (2016)

Warfarin Use and Risk of Stroke in Patients With Atrial Fibrillation Undergoing Hemodialysis: A Meta-Analysis
by: Lee, Meng, et al.
Published: (2016)

A new model to predict major bleeding in patients with atrial fibrillation using warfarin or direct oral anticoagulants.
by: J'Neka S Claxton, et al.

Implementing hospital guidelines improves warfarin use in non-valvular atrial fibrillation: a before-after study
by: Bo, Simona, et al.
Published: (2007)

Predictors of warfarin use in atrial fibrillation in the United States: a systematic review and meta-analysis
by: Baczek, Victoria L, et al.
Published: (2012)

Patterns of Warfarin Use in Subgroups of Patients with Atrial Fibrillation: A Cross-Sectional Analysis of 430 General Practices in the United Kingdom
by: Mohammed, Mohammed A., et al.
Published: (2013)

A Comparative Analysis of Models Used to Evaluate the Cost-Effectiveness of Dabigatran Versus Warfarin for the Prevention of Stroke in Atrial Fibrillation
by: Sorensen, Sonja V., et al.
Published: (2013)

Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
by: Laliberté, François, et al.
Published: (2015)

Erratum to: Effect of Rivaroxaban Versus Warfarin on Health Care Costs Among Nonvalvular Atrial Fibrillation Patients: Observations from Rivaroxaban Users and Matched Warfarin Users
by: Laliberté, François, et al.
Published: (2015)

THE CONTROL OF INTERNATIONAL NORMALISED RATIO IN PATIENTS WITH ATRIAL FIBRILLATION TREATED WITH WARFARIN IN OUTPATIENT AND HOSPITAL SETTINGS: DATA FROM RECVASA REGISTRIES
by: M. M. Loukianov, et al.
Published: (2018-01-01)

Comparative effectiveness of novel oral anticoagulants for atrial fibrillation: evidence from pair-wise and warfarin-controlled network meta-analyses
by: Biondi-Zoccai, G, et al.
Published: (2013)

Impact of stated barriers on proposed warfarin prescription for atrial fibrillation: a survey of Canadian physicians
by: Nicholls, Stuart G, et al.
Published: (2014)

Cost-Effectiveness of Dabigatran versus Genotype-Guided Management of Warfarin Therapy for Stroke Prevention in Patients with Atrial Fibrillation
by: You, Joyce H. S., et al.
Published: (2012)

SPECIAL CONSIDERATIONS REGARDING WARFARIN DOSE TITRATION IN PATIENTS WITH ATRIAL FIBRILLATION DEPENDING ON CLINICAL FACTORS
by: E. L. Artanova, et al.
Published: (2011-01-01)

Prediction of individual combined benefit and harm for patients with atrial fibrillation considering warfarin therapy: a study protocol
by: Li, Guowei, et al.
Published: (2015)

Prediction of rates of thromboembolic and major bleeding outcomes with dabigatran or warfarin among patients with atrial fibrillation: new initiator cohort study
by: Wang, Shirley V, et al.
Published: (2016)

Incidence of thromboembolic stroke and of major bleeding in patients with atrial fibrillation and chronic kidney disease treated with and without warfarin
by: Lai, Hoang M, et al.
Published: (2009)

Population-based cohort study of warfarin-treated patients with atrial fibrillation: incidence of cardiovascular and bleeding outcomes
by: Gallagher, Arlene M, et al.
Published: (2014)

Dabigatran, Rivaroxaban, or Apixaban versus Warfarin in Patients with Nonvalvular Atrial Fibrillation: A Systematic Review and Meta-Analysis of Subgroups
by: Gómez-Outes, Antonio, et al.
Published: (2013)